Introduction A comprehensive analytical data package prepared for an Investigational New Drug (IND) submission provides regulatory agencies with robust structural, […]
Introduction Developing and implementing a scientifically optimized Reversed-Phase HPLC Method Development strategy is a fundamental analytical requirement for accurately determining
Introduction: Setting a therapeutic peptide API purity specification is one of the most consequential — and most frequently misjudged —
Introduction The structural characterization of biomolecular assemblies increasingly depends on Native Mass Spectrometry for Therapeutic Peptide Characterization, as it enables
Introduction: Peptide therapeutics are one of the fastest-growing drug classes in the pharmaceutical pipeline, but their structural complexity demands rigorous
Introduction Peptide physicochemical characterization services establish the scientific basis required to confirm the molecular identity, therapeutic suitability, and regulatory compliance
Introduction: Advanced Advancements in Peptide Impurity Identification and Characterization Services Peptide Impurity Identification and Characterization Services are specialized analytical solutions
Multi-Attribute Monitoring (MAM) for Therapeutic Peptide Characterization: A Modern LC-MS Workflow Introduction Liquid chromatography-mass spectrometry (LC-MS)-based Multi-Attribute Monitoring (MAM) has
Introduction: The landscape of incretin-based therapies has expanded far beyond the first-generation GLP-1 receptor agonists. Regulatory submissions for GLP-2 and
Modern Analytical Platforms for Peptide Mapping and Sequence Analysis This section explains how high-resolution mass spectrometry combined with liquid chromatography
Peptide Mapping and Sequence Analysis Services for Biosimilars Read More »
